Examining the synthetic anxiolytic heptapeptide derived from tuftsin with enhanced enzymatic stability.
Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structurally modified analog of tuftsin, a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) that plays a role in immune system modulation. The key modification in Selank is the addition of a C-terminal Pro-Gly-Pro glyproline sequence to the native tuftsin backbone. This extension was specifically engineered to confer resistance to enzymatic degradation, significantly improving the peptide's biological half-life compared to unmodified tuftsin.
With a molecular weight of approximately 751 Da, Selank is a compact yet functionally significant peptide that has attracted considerable research interest. It is frequently studied alongside Semax, another Russian-developed neuropeptide, as both compounds belong to a class of synthetic regulatory peptides investigated for their effects on the central nervous system and immune function.
The development of Selank emerged from decades of research into tuftsin and its immunomodulatory properties. Scientists at the Institute of Molecular Genetics recognized that while tuftsin demonstrated promising biological activity, its rapid degradation by tissue peptidases severely limited its utility in research settings. By appending the glyproline tripeptide Pro-Gly-Pro, they created a molecule that retained the parent peptide's activity profile while exhibiting substantially improved stability in biological environments.
Preclinical studies have investigated Selank across a range of neurobiological research domains. In rodent models, researchers have examined its anxiolytic-like effects, observing behavioral changes in elevated plus maze and open field tests that suggest modulation of anxiety-related pathways. Additional studies have explored Selank's influence on neuropeptide expression patterns, with particular attention to its interactions with enkephalin metabolism and monoamine neurotransmitter systems. The peptide has also been studied in the context of adaptive stress responses, where investigators have assessed its effects on behavioral and physiological markers under controlled experimental conditions.
Selank's heptapeptide structure — Thr-Lys-Pro-Arg-Pro-Gly-Pro — combines the biologically active core of tuftsin (residues 1-4) with a stabilizing glyproline tail (residues 5-7). The molecular weight of approximately 751 Da places it among the smaller research peptides, which contributes to favorable solubility and handling characteristics. The presence of multiple proline residues within the sequence creates a constrained backbone geometry that contributes to the peptide's resistance to proteolytic cleavage.
The glyproline motif Pro-Gly-Pro is itself a subject of research interest, as proline-rich sequences are known to adopt polyproline II helical conformations that can influence peptide-receptor interactions and metabolic stability. This structural feature is central to Selank's improved pharmacokinetic profile relative to native tuftsin.
Selank is utilized across several active research areas. In neuroscience, investigators study its effects on GABAergic signaling, as preclinical data suggest the peptide may interact with GABA receptor systems to modulate inhibitory neurotransmission. Research into neurotrophic factors has examined Selank's influence on brain-derived neurotrophic factor (BDNF) expression, a key molecule involved in neuronal survival, synaptic plasticity, and memory formation.
Immunological research with Selank explores the peptide's effects on cytokine profiles, immune cell activation, and inflammatory mediator expression — building on the well-characterized immunomodulatory properties of its parent molecule tuftsin. Researchers have also investigated its potential role in modulating gene expression related to immune signaling pathways.
In cognitive research paradigms, Selank has been examined in memory and learning models in rodents, where investigators assess performance in tasks such as the Morris water maze and passive avoidance tests. These studies contribute to the broader understanding of how regulatory peptides may influence cognitive processes at the molecular level. Like Semax, Selank occupies a prominent position in the nootropic research peptide category and is frequently included in comparative studies of neuropeptide function.
Selank is supplied as a 10mg lyophilized (freeze-dried) powder priced at $30. For long-term storage, the lyophilized peptide should be maintained at -20°C, where it remains stable for extended periods. Once reconstituted with bacteriostatic water or sterile saline, the solution should be stored at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles, as thermal stress can compromise peptide integrity. Always handle with appropriate laboratory gloves and employ sterile technique during reconstitution to prevent microbial contamination.
This product is sold exclusively for laboratory and scientific research purposes. It is not intended for human or veterinary use, diagnostic purposes, or therapeutic applications. All research must comply with applicable laws and institutional guidelines. By purchasing, you confirm you are a qualified researcher. Please review our full legal disclaimer.